Litcius/Paper detail

Assessment of Immune-Related Interstitial Lung Disease in Patients With NSCLC Treated with Immune Checkpoint Inhibitors: A Multicenter Prospective Study

Yuzo Suzuki, Masato Karayama, Tomohiro Uto, Masato Fujii, Takashi Matsui, Kazuhiro Asada, Hideki Kusagaya, Masato Kato, Hiroyuki Matsuda, Shun Matsuura, Mikio Toyoshima, Kazutaka Mori, Yasuhiro Ito, Takafumi Koyauchi, Hideki Yasui, Hironao Hozumi, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Yutaro Nakamura, Naoki Inui, Takafumi Suda

2020Journal of Thoracic Oncology107 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInterstitial lung diseaseImmune systemOncologyMulticenter studyProspective cohort studyImmune checkpointLung cancerInternal medicineDiseaseLungImmunotherapyImmunologyRandomized controlled trialCancer Immunotherapy and BiomarkersInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisInflammatory Myopathies and Dermatomyositis
Assessment of Immune-Related Interstitial Lung Disease in Patients With NSCLC Treated with Immune Checkpoint Inhibitors: A Multicenter Prospective Study | Litcius